|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1701 N. BEAUREGARD STREET |
Address2 | |
City | ALEXANDRIA |
State | VA |
Zip Code | 22311 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 2230-12
|
||||||||
|
6. House ID# 321920000
|
TYPE OF REPORT | 8. Year | 2011 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Shereen Arent, Executive VP Government Affairs & Advocacy |
Date | 10/14/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S. 365, Budget Control Act, S. 1599/H.R.3070 Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations Act for FY12 Multiple clauses, Opposing cost-shifting, cuts to or the block granting of federal entitlement programs, specifically Medicaid and Medicare.
Please see next page
S. 365, Budget Control Act. The Act increased the debt ceiling and included provisions requiring substantial cuts in federal spending to achieve further reductions in the nations debt. All sectors of the federal budget will be on the table, including entitlement spending and taxes, which has an impact on programs at NIH, CDC, as well as Medicaid and Medicare. (Lobbyist: Lisa Cox, Amy Wotring)
S. 1599/H.R.3070 Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations Act for FY12 Multiple clauses; Provides funding for the Division of Diabetes Translation (DDT) at the Centers for Disease Control and Prevention (CDC) as well as funding for research at the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH). Our efforts are focused on increased funding for both of these agencies, on behalf of those who will benefit from the research and education/information programs that they provide. Additionally, we are interested in the allocation of $80 million for the implementation of the National Diabetes Prevention Program (NDPP), which was enacted through the Patient Protection and Affordable Care Act and would like to see it funded through the Public Health and Prevention Fund, also enacted in the health care reform law. (Lobbyists used: Tekisha Dwan Everette, Lisa Cox, Meghan Riley, Amy Wotring)
Issues worked on the Hill not yet reflected in legislation:
Opposing cost-shifting, cuts to or the block granting of federal entitlement programs, specifically Medicaid and Medicare. In addition, opposing the repeal of the Medicaid maintenance of effort provision. (Lobbyists used: Tekisha Dwan Everette, Lisa Cox, Amy Wotring)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Natl Institutes of Health (NIH), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lisa |
Cox |
|
|
|
Tekisha |
Everette |
|
|
|
Meghan |
Riley |
|
|
|
Amy |
Wotring |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1057/S. 576, The Fitness Integrated in Teaching (FIT) Kids Act, H.R. 2194/S.1221. The Gestational Diabetes Act (GeDi Act), H.R. 2954, The Health Equity and Accountability Act, The Eliminating Disparities in Diabetes Prevention, Access and Care Act.
Please see next page
H.R. 1057/S. 576, The Fitness Integrated in Teaching (FIT) Kids Act. Support entire bill. Supports physical education for public school children grades K-12. Requires schools to report on the quality and quantity of physical education offered, supports professional development opportunities for teachers and principals to promote student health, requires nutritional education and structured physical activity for students, and authorizes a study to examine the impact of health and physical activity on student achievement. (Lobbyist used: Meghan Riley)
H.R. 2194/S.1221. The Gestational Diabetes Act (GeDi Act) - Support entire bill; Legislation expands screening, diagnosis, data collection and treatment of gestational diabetes and the children born from women with gestational diabetes. (Lobbyists used: Amy Wotring)
H.R. 2954, The Health Equity and Accountability Act. Support provisions. Comprehensive health disparities legislation with specific diabetes provisions included in the bill: the Gestational Diabetes Act and the Eliminating Disparities in Diabetes Prevention, Access and Care Act. (Lobbyist used: Meghan Riley)
Issues worked on the Hill not yet reflected in legislation:
The Eliminating Disparities in Diabetes Prevention, Access and Care Act Support entire bill: Would expand resources at NIH, CDC, and HRSA to promote research, treatment, and education regarding diabetes in minority populations. This legislation was amended and passed the House on September 28, 2010. Advocated for Senate consideration of House-passed H.R. 1995 during the final quarter of 2010. (Lobbyists used: Meghan Riley)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Meghan |
Riley |
|
|
|
Amy |
Wotring |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
H.R. 4808, the Stem Cell Enhancement Act. Support bill. Legislation codifies the Obama Administrations Executive Order and National Institutes of Health guidelines regarding federal funding of human embryonic stem cell research. (Lobbyists used: Lisa Cox)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lisa |
Cox |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2195/S. 1203, The Medicare Home Infusion Therapy Coverage Act, The Diabetes Screening and Medicaid Savings Act , Medicare Competitive Bidding Program
Please see next page
H.R. 2195/S. 1203, The Medicare Home Infusion Therapy Coverage Act. Support entire bill. Legislation ensures safe and effective provision of home infusion therapy and provides coverage under Medicare Part B for infusion-related services, equipment, and supplies. (Lobbyist used: Amy Wotring)
Issues worked on the Hill not yet reflected in legislation
The Diabetes Screening and Medicaid Savings Act Support entire bill; Requires states to provide diabetes screening tests under the Medicaid program for adult enrollees with diabetes risk factors and further requires states to provide a comprehensive package of benefits under the Medicaid program for individuals with diabetes. (Lobbyists used: Amy Wotring)
Medicare Competitive Bidding Program Oppose specific provisions; monitoring implementation of round 1 of the Medicare Competitive Bidding Program (CBP) which went into effect on January 1, 2011 and includes mail order diabetes testing supplies which have accounted for approximately 75% of product category specific inquiries (13,813) to CMS in the 1st quarter of 2011. Oppose bringing retail into competitive bidding. (Lobbyists used: Amy Wotring & Tekisha Dwan Everette)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tekisha |
Everette |
|
|
|
Amy |
Wotring |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |